Infertility
Conditions
Interventions
study group:Luteal-phase support was administered using allylestrenol tablets and dydrogesterone tablets.
control group:Luteal-phase support was provided using progesterone vaginal sustained-release gel and dydrogesterone tablets.
Sponsors
Sichuan Provincial Women and Children's Hospital
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Women of reproductive age between 20 and 40 years, undergoing their first IVF-ET treatment, with controlled ovarian stimulation using a gonadotropin-releasing hormone antagonist protocol, and receiving fresh embryo transfer.
Exclusion criteria
Exclusion criteria: Exclusion criteria: uterine factors affecting embryo implantation (such as uterine malformations, submucosal or intramural fibroids, adenomyosis), history of recurrent pregnancy loss, use of donor sperm, preimplantation genetic testing, contraindications to allylestrenol or progesterone gel, and body mass index 28.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Live birth rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Embryo implantation rate;Biochemical pregnancy loss rate;Ongoing pregnancy rate;Early miscarriage rate;Multiple pregnancy rate; | — |
Countries
China
Contacts
Public ContactGong Yan
Sichuan Provincial Women and Children's Hospital
Outcome results
None listed